Scope and Methodology
This report on the vial adaptors for reconstitution drug market analyzes the current and future prospects of the market globally. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn and volume in terms of million units for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global vial adaptors for reconstitution drug market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global vial adaptors for reconstitution drug market.
Market revenue in terms of US$ Mn and volume in terms of million units for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2019 to 2026 are provided for all the segments, considering 2018 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Segmentation
Based on product type, the global vial adaptors for reconstitution drug market has been segmented into 13mm vial adaptor and 20mm vial adaptor. The market has been further studied from the point of view of major material. Based on material, the market has been categorized into polycarbonate, silicon, polyethylene teraphthalate glycol, polyethylene, and others. On the basis of therapeutic area, the market has been segmented autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. On the basis of delivery mode, the market has been segmented injection and infusion.
Geographical and Competitive Dynamics
Geographically, the global vial adaptors for reconstitution drug market has been segmented into five regions: North America, Europe, Asia Pacific, and Rest of World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, and Japan.
Key Players Mentioned in the Report are:
The global vial adaptors for reconstitution drug market is consolidated in which relatively small number of companies accounted for majority market share. Major players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc.
The global vial adaptors for reconstitution drug market has been segmented as follows:
By Product Type
By Material
By Therapeutic Area
By Delivery Mode
By Geography
Section - 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section - 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global Vial Adaptors for Reconstitution Drug: Market Snapshot
3.2 Global Vial Adaptors for Reconstitution Drug Market: Opportunity Map
Section-4 Market Dynamics
4.1 Drivers and Restraints Snapshot Analysis
4.1.2 Drivers
4.1.2.1 Safety Concerns
4.1.2.2 Aging Population
4.1.2.3 Increasing Prevalence of Infectious Diseases
4.1.2.4 Reduced Drug Overfill
4.1.2.5 Increasing demand for lyophilized drug
4.1.2.6 No risk of contamination or drug spillage
4.1.3 Restraints
4.1.3.1 Vial adaptors usage requires further customization in some cases
4.1.3.2 Availability of substitutes
4.1.4 Opportunity Analysis
4.1.4.1 Technological Advancement
4.1.4.2 Expansion toward Developing Nations
4.3 Global Vial Adaptors for Reconstitution Drug Market Revenue Projection
4.4 Porter’s Five Forces Analysis
4.5 Value Chain Analysis
4.6 Vial Adaptors for Reconstitution Drug Market Outlook
Section-5 Vial Adaptors for Reconstitution Drug Market Analysis By Product Type
5.1 Key Findings
5.2 Introduction
5.3 Global Vial Adaptors for Reconstitution Drug Market Value Share Analysis, By Product Type
5.4 Global Vial Adaptors for Reconstitution Drug Market Forecast By Product Type
5.4.1 13mm Vial Adaptors
5.4.2 20mm Vial Adaptors
5.5 Global Vial Adaptors for Reconstitution Drug Market Attractiveness Analysis By Product Type
Section-6 Global Vial Adaptors for Reconstitution Drug Market Analysis By Material
6.1 Key Findings
6.2 Introduction
6.3 Global Vial Adaptors for Reconstitution Drug Market Value Share Analysis, By Material
6.4 Global Vial Adaptors for Reconstitution Drug Market Forecast, By Material
6.4.1 Polycarbonate
6.4.2 Silicon
6.4.3 Polyethylene Teraphthalate Glycol
6.4.4 Polyethylene
6.4.5 Others
6.5 Global Vial Adaptors for Reconstitution Drug Market Attractiveness Analysis, By Material
Section-7 Global Vial Adaptors for Reconstitution Drug Market Analysis, By Therapeutic Area
7.1 Key Findings
7.2 Introduction
7.3 Global Vial Adaptors for Reconstitution Drug Market Value Share Analysis, By Therapeutic Area
7.4 Global Vial Adaptors for Reconstitution Drug Market Forecast, By Therapeutic Area
7.4.1 Autoimmune Diseases
7.4.2 Infectious Diseases
7.4.3 Metabolic Conditions
7.4.4 Reproductive Health
7.4.5 Others
7.5 Global Vial Adaptors for Reconstitution Drug Market Attractiveness Analysis, By Therapeutic Area
Section-8 Global Vial Adaptors for Reconstitution Drug Market Analysis, By Delivery Mode
8.1 Key Findings
8.2 Introduction
8.3 Global Vial Adaptors for Reconstitution Drug Market Value Share Analysis, By Therapeutic Area
8.4 Global Vial Adaptors for Reconstitution Drug Market Forecast, By Delivery Mode
8.4.1 Injection
8.4.2 Infusion
8.5 Global Vial Adaptors for Reconstitution Drug Market Attractiveness Analysis, By Delivery Mode
Section-9 Global Vial Adaptors for Reconstitution Drug Market Analysis, By Region
9.1 Global Market Scenario
9.2 Global Vial Adaptors for Reconstitution Drug Market Value Share Analysis, By Region
9.2.1 Global Vial Adaptors for Reconstitution Drug Market Forecast By Region
9.3 Global Vial Adaptors for Reconstitution Drug Market Attractiveness Analysis, By Region
Section-10 North America Vial Adaptors for Reconstitution Drug Market Analysis
10.1 North America Vial Adaptors for Reconstitution Drug Market Overview
10.2 North America Market Value Share Analysis, By Product Type
10.2.1 North America Market Forecast By Product Type
10.3 North America Market Value Share Analysis, By Material
10.3.1 North America Market Forecast By Material
10.4 North America Market Value Share Analysis, By Therapeutic Area
10.4.1 North America Market Value Share Analysis, By Therapeutic Area
10.5. North America Market Value Share Analysis, By Delivery Mode
10.5.1 North America Market Value Share Analysis, By Delivery Mode
10.6 North America Market Forecast By Country
10.7 North America Market Attractiveness Analysis
10.8 North America Market Trends
Section-11 Europe Vial Adaptors for Reconstitution Drug Market Analysis
11.1 Europe Vial Adaptors for Reconstitution Drug Market Overview
11.2 Europe Market Value Share Analysis, By Product Type
11.2.1 Europe Market Forecast By Product Type
11.3 Europe Market Value Share Analysis, By Material
11.3.1 Europe Market Forecast By Material
11.4 Europe Market Value Share Analysis, By Therapeutic Area
11.4.1 Europe Market Value Share Analysis, By Therapeutic Area
11.5 Europe Market Value Share Analysis, By Delivery Mode
11.5.1 Europe Market Value Share Analysis, By Delivery Mode
11.6 Europe Market Forecast By Country
11.7 Europe Market Attractiveness Analysis
11.8 Europe Market Trends
Section-12 Asia Pacific Vial Adaptors for Reconstitution Drug Market Analysis
12.1 Asia Pacific Vial Adaptors for Reconstitution Drug Market Overview
12.2 Asia Pacific Market Value Share Analysis, By Product Type
12.2.1 Asia Pacific Market Forecast By Product Type
12.3 Asia Pacific Market Value Share Analysis, By Material
12.3.1 Asia Pacific Market Forecast By Material
12.4 Asia Pacific Market Value Share Analysis, By Therapeutic Area
12.4.1 Asia Pacific Market Value Share Analysis, By Therapeutic Area
12.5 Asia Pacific Market Value Share Analysis, By Delivery Mode
12.5.1 Asia Pacific Market Value Share Analysis, By Delivery Mode
12.6 Asia Pacific Market Forecast By Country
12.7 Asia Pacific Market Attractiveness Analysis
12.8 Asia Pacific Market Trends
Section-13 Rest of the World Vial Adaptors for Reconstitution Drug Market Analysis
13.1 Rest of the World Vial Adaptors for Reconstitution Drug Market Overview
13.2 Rest of the World Market Value Share Analysis, By Product Type
13.2.1 Rest of the World Market Forecast By Product Type
13.3 Rest of the World Market Value Share Analysis, By Material
13.3.1 Rest of the World Market Forecast By Material
13.4 Rest of the World Market Value Share Analysis, By Therapeutic Area
13.4.1 Rest of the World Market Value Share Analysis, By Therapeutic Area
13.5 Rest of the World Market Value Share Analysis, By Delivery Mode
13.5.1 Rest of the World Market Value Share Analysis, By Delivery Mode
13.6 Rest of the World Market Attractiveness Analysis
13.7 Rest of the World Market Trends
Section-14 Competition Landscape
14.1 Market Share Analysis, by Key Players, 2015
14.2 Competition Matrix
14.3 Company Profiles
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Business Overview
14.3.1.3 Financial Overview
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2 Becton, Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 SWOT Analysis
14.3.2.5 Strategic Overview
14.3.3 Cardinal Health, Inc.
14.3.3.1 Company Overview
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4 Sensile Medical AG
14.3.4.1 Company Overview
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 SWOT Analysis
14.3.4.5 Strategic Overview
14.3.5 Unilife Corporation
14.3.5.1 Company Overview
14.3.5.2 Business Overview
14.3.5.3 Financial Overview
14.3.5.4 SWOT Analysis
14.3.5.5 Strategic Overview
14.3.6 West Pharmaceutical Services, Inc.
14.3.6.1 Company Overview
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers